For those using tirzepatide to manage blood sugar or metabolic markers, unexplained worsening of these markers after stable control could indicate potency loss from improper storage
Additionally, we collated an extensive panel of clinical and laboratory parameters, such as diabetes duration, blood pressure, glycemic marker (HbA1c, plasma glucose) levels, liver enzyme [alanine aminotransferase (ALT), -glutamyl transpeptidase (-GTP)] levels, renal function [serum creatinine level, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR)], lipid profile, and uric acid level
Weight loss appears to play a meaningful role, since adipose tissue is a known driver of pro-inflammatory cytokines
Medical Weight Loss as Part of a Larger Care Strategy Medical weight loss is not intended to replace a healthy lifestyle, and it is not a standalone solution for every patient
Table of Contents What Is NAD+ and How Do Subcutaneous Injections Work